ScoreComparison
Why is Day One Biopharmaceuticals, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -21.62% over the last 5 years
2
The company has declared negative results in Jan 70 after 4 consecutive negative quarters
- NET SALES(Q) At USD 39.8 MM has Fallen at -57.56%
- PRE-TAX PROFIT(Q) At USD -19.73 MM has Fallen at -154.56%
- NET PROFIT(Q) At USD -19.73 MM has Fallen at -153.26%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 161.42%, its profits have fallen by -80.1%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Day One Biopharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Day One Biopharmaceuticals, Inc.
172.53%
0.70
102.06%
S&P 500
25.41%
0.62
19.30%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-21.62%
EBIT Growth (5y)
-223.62%
EBIT to Interest (avg)
-128.24
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.99
Sales to Capital Employed (avg)
0.25
Tax Ratio
11.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.89
EV to EBIT
-10.60
EV to EBITDA
-10.83
EV to Capital Employed
-1755.02
EV to Sales
13.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-33.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
NET SALES(Q)
Highest at USD 53.72 MM
OPERATING PROFIT MARGIN(Q)
Highest at -49.26 %
RAW MATERIAL COST(Y)
Fallen by 1.25% (YoY
PRE-TAX PROFIT(Q)
At USD -23.25 MM has Grown at 60.75%
NET PROFIT(Q)
At USD -21.28 MM has Grown at 67.62%
-11What is not working for the Company
NET SALES(HY)
At USD 93.51 MM has Grown at -23.95%
NET PROFIT(HY)
At USD -41 MM has Grown at -42.99%
Here's what is working for Day One Biopharmaceuticals, Inc.
Net Sales
Highest at USD 53.72 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
At USD 53.72 MM has Grown at 83.92%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -49.26 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
At USD -23.25 MM has Grown at 60.75%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -21.28 MM has Grown at 67.62%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by 1.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
